We are live on ! Find out more
CA

Continuum Advisory Portfolio holdings

AUM $1.04B
1-Year Est. Return 21.13%
This Fund
S&P 500
This Quarter Est. Return
+9.05%
1 Year Est. Return
+21.13%
3 Year Est. Return
+59.21%
5 Year Est. Return
+68.09%
10 Year Est. Return
AUM
$831M
AUM Growth
+$54.3M
Cap. Flow
-$782K
Cap. Flow %
-0.09%
Top 10 Hldgs %
27.48%
Holding
1,660
New
4
Increased
253
Reduced
141
Closed
1,237

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$4.49M
2
CRM icon
Salesforce
CRM
+$4.36M
3
NEM icon
Newmont
NEM
+$4.31M
4
ULTA icon
Ulta Beauty
ULTA
+$4.31M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$4.19M

Sector Composition

Rank Sector Weight
1 Technology 12.24%
2 Financials 5.07%
3 Healthcare 5.06%
4 Consumer Discretionary 3.63%
5 Communication Services 3.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRE icon
351
Sempra
SRE
$57.9B
$280K 0.03%
3,691
+101
+3% +$7.5K
VRT icon
352
Vertiv
VRT
$93B
$278K 0.03%
2,165
+533
+33% +$51.8K
BA icon
353
Boeing
BA
$171B
$277K 0.03%
1,320
+97
+8% +$18.3K
NUDM icon
354
Nuveen ESG International Developed Markets Equity ETF
NUDM
$707M
$275K 0.03%
7,752
-2
-0% -$67
MCK icon
355
McKesson
MCK
$100B
$274K 0.03%
374
+55
+17% +$38.8K
GIS icon
356
General Mills
GIS
$19.1B
$272K 0.03%
5,248
+849
+19% +$46.8K
IDMO icon
357
Invesco S&P International Developed Momentum ETF
IDMO
$4.08B
$271K 0.03%
+5,286
New +$252K
MSTR icon
358
Strategy Inc
MSTR
$34.1B
$268K 0.03%
662
+42
+7% +$15.3K
GSK icon
359
GSK
GSK
$104B
$267K 0.03%
6,956
-4,973
-42% -$190K
DOW icon
360
Dow Inc
DOW
$21.9B
$266K 0.03%
10,049
+7,142
+246% +$208K
SGOV icon
361
iShares 0-3 Month Treasury Bond ETF
SGOV
$99.4B
$266K 0.03%
2,638
SPHD icon
362
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.34B
$265K 0.03%
5,562
-6,587
-54% -$311K
VCIT icon
363
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$263K 0.03%
3,173
-327
-9% -$26.6K
IGRO icon
364
iShares International Dividend Growth ETF
IGRO
$1.3B
$263K 0.03%
3,335
+2,921
+706% +$221K
ESGE icon
365
iShares ESG Aware MSCI EM ETF
ESGE
$6.58B
$261K 0.03%
6,657
+2
+0% +$72
XMHQ icon
366
Invesco S&P MidCap Quality ETF
XMHQ
$5.47B
$259K 0.03%
2,638
-126
-5% -$11.9K
IAU icon
367
iShares Gold Trust
IAU
$62.9B
$258K 0.03%
4,144
-678
-14% -$42K
CB icon
368
Chubb
CB
$135B
$256K 0.03%
885
+724
+450% +$208K
MUNI icon
369
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
$3.06B
$256K 0.03%
4,980
SO icon
370
Southern Company
SO
$109B
$254K 0.03%
2,763
-143
-5% -$12.8K
LHX icon
371
L3Harris
LHX
$51.6B
$254K 0.03%
1,011
-293
-22% -$67.3K
SPOT icon
372
Spotify
SPOT
$103B
$250K 0.03%
326
+31
+11% +$19.9K
IUSG icon
373
iShares Core S&P US Growth ETF
IUSG
$31.7B
$244K 0.03%
1,624
ES icon
374
Eversource Energy
ES
$26.9B
$244K 0.03%
3,830
+1,105
+41% +$68.1K
ZMAR
375
Innovator Equity Defined Protection ETF - 1 Yr March
ZMAR
$113M
$243K 0.03%
9,154
+7,205
+370% +$187K

Similar funds

Continuum Advisory's Q2 2025 Portfolio in Review

As of Q2 2025, Continuum Advisory held 1,660 positions worth $831M, up 7% from $776M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Continuum Advisory's Q2 2025 filing shows 4 new, 253 increased, 141 reduced and 1,237 closed positions. Its largest new stake was Ulta Beauty: 10,430 shares worth $4.88M. The largest sale was Berkshire Hathaway Class A, an estimated $6.09M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Continuum Advisory's largest Q2 2025 buy was Ulta Beauty: 10,430 shares worth $4.88M.
  • Continuum Advisory added most to CVS Health in Q2 2025, an estimated $4.49M increase.
  • Continuum Advisory's biggest Q2 2025 reduction was Berkshire Hathaway Class A, cutting an estimated $6.09M.
  • Continuum Advisory fully exited Hartford Financial Services in Q2 2025, selling an estimated $4.63M.
  • Continuum Advisory's ten largest holdings make up 27% of its $831M portfolio in Q2 2025.
  • Continuum Advisory opened 4 new positions and closed 1,237 in Q2 2025.
  • Continuum Advisory's portfolio value rose 7% quarter-over-quarter to $831M.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.